NY State Senate Bill 2019-S4423

Senate Bill S4423

Signed By Governor

2019-2020 Legislative Session

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund

download bill text pdf

Archive: Last Bill Status Via A4481 - Signed by Governor

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Sep 13, 2019	signed chap.266 delivered to governor
Jun 19, 2019	returned to assembly passed senate 3rd reading cal.1768 substituted for s4423
Jun 19, 2019	substituted by a4481 ordered to third reading cal.1768 committee discharged and committed to rules
Mar 11, 2019	referred to health

Votes

- Jun 19, 2019 - Floor Vote
  A4481
  
  62
  
  Aye
  
  0
  
  Nay
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Floor Vote: Jun 19, 2019
      
      aye (62)
      
      Addabbo Jr.
      
      Akshar
      
      Amedore
      
      Antonacci
      
      Bailey
      
      Benjamin
      
      Biaggi
      
      Boyle
      
      Breslin
      
      Brooks
      
      Carlucci
      
      Comrie
      
      Felder
      
      Flanagan
      
      Funke
      
      Gallivan
      
      Gaughran
      
      Gianaris
      
      Gounardes
      
      Griffo
      
      Harckham
      
      Helming
      
      Hoylman-Sigal
      
      Jackson
      
      Jacobs
      
      Jordan
      
      Kaminsky
      
      Kaplan
      
      Kavanagh
      
      Kennedy
      
      Krueger
      
      LaValle
      
      Lanza
      
      Little
      
      Liu
      
      Martinez
      
      May
      
      Mayer
      
      Metzger
      
      Montgomery
      
      Myrie
      
      O'Mara
      
      Ortt
      
      Parker
      
      Persaud
      
      Ramos
      
      Ranzenhofer
      
      Ritchie
      
      Rivera
      
      Robach
      
      Salazar
      
      Sanders Jr.
      
      Savino
      
      Sepúlveda
      
      Serino
      
      Serrano
      
      Seward
      
      Skoufis
      
      Stavisky
      
      Stewart-Cousins
      
      Tedisco
      
      Thomas
  Jun 19, 2019 - Rules Committee Vote
  S4423
  
  19
  
  Aye
  
  0
  
  Nay
  
  0
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Rules Committee Vote: Jun 19, 2019
      
      aye (19)
      
      Benjamin
      
      Breslin
      
      Comrie
      
      Flanagan
      
      Gianaris
      
      Griffo
      
      Hoylman-Sigal
      
      Kennedy
      
      Krueger
      
      LaValle
      
      Lanza
      
      Little
      
      Liu
      
      Martinez
      
      Parker
      
      Robach
      
      Savino
      
      Seward
      
      Stewart-Cousins

2019-S4423 (ACTIVE) - Details

See Assembly Version of this Bill:: A4481
Law Section:: Public Health Law
Laws Affected:: Add Art 27-CCC §2747, Pub Health L; add §§209-M & 630-g, Tax L; add §97-ssss, St Fin L
Versions Introduced in Other Legislative Sessions:: 2009-2010: A3075
2011-2012: A283
2013-2014: A558
2015-2016: S1657, A49
2017-2018: S970, A1354

2019-S4423 (ACTIVE) - Summary

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift on individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

2019-S4423 (ACTIVE) - Sponsor Memo

                                
 
BILL NUMBER: S4423

SPONSOR: ROBACH
 
TITLE OF BILL:  An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer gifts for
leukemia, lymphoma and myeloma research, education and treatment and
establishing the leukemia, lymphoma and myeloma research, education and
treatment fund

 
PURPOSE OR GENERAL IDEA OF BILL:

The purpose of this bill is to provide easy access to help fund and
support Leukemia, Lymphoma, and Myeloma research, education and treat-
ment.

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 - Amends the public health law by adding a new article 27-CCC.
The new article provides the Commissioner of Health with the powers to:
develop programs concerning Leukemia, Lymphoma, and Myeloma, to accept
and expend grants, awards and other funding, and to enter into contracts

necessary for program development and granting.

Section 2 - Amends the law by adding a new section 209-K. The new
section provides for the Commissioner of Taxation and Finance to include
a space on the corporate income tax return for contributions to Leuke-
mia, Lymphoma, and Myeloma research, education and treatment.

Section 3 - Amends part 2 of article 22 of the tax law by adding new
section 630-e. The new section provides for the Commissioner of Taxation
and Finance to include a space on the individual income tax return for
contributions to Leukemia, Lymphoma, and Myeloma research, education and
treatment.

Section 4 - Amends the state finance law by adding a new section
97-pppp. The new section provides for the establishment of a special
fund, consisting of revenues received under section 209-K and 630-E of
the tax law and any other moneys appropriated, credited or transferred,
for Leukemia, Lymphoma and Myeloma research, education and treatment.
The custody of this fund will be held jointly by the Commissioner of
Taxation and Finance and the Comptroller. The Commissioner of Health
shall provide a written report on or before the first day of February
each year to the Senate, Assembly, Senate Finance Committee, Assembly
Ways and Means Committee, the Senate and Assembly Health Committee's,
the State Comptroller and the public.

Further, the new section provides that all monies in the fund to be used
only for Leukemia, Lymphoma and Myeloma research, education and treat-
ment programs approved by the Department of Health. Additionally, the
new section provides that the Comptroller must approve releases of money
that are certified by the Commissioner of Health and that all money in
the fund should be used prior to the end of the fiscal year.

Section 5 - The effective date.

 
JUSTIFICATION:

Research and treatment efforts for many diseases, including Alzheimer's
and breast cancer, have benefited from additional funding resulting from
having a "check-off box" placed on the individual and corporate income
tax returns. Leukemia, Lymphoma and Myeloma are blood cancers originat-
ing in the bone marrow and correlate with each other because of the
unrestrained growth of the cells and the parallel functions which they
possess. Leukemia, although more common in adults over the age of 64, is
still the leading cause of disease death of children under 15 yrs old,
with Acute Lymphocytic Leukemia (ALL) being the most common form of
Leukemia in children. Treatment advances for Leukemia have proven to be
prevalent in the survival rate over the years, with the survival rate
increasing from 415 in 1960 to 85% in 1999. Lymphoma involves two
particular forms including Non-Hodgkin, which is the fifth most common
cancer in the U.S. and Hodgkin Lymphoma, which mostly affects adoles-
cents and young adults. Myeloma occurs mostly in people over 60 yrs old
with males having a 50% higher chance than females of being diagnosed.
Each year an estimated 106,200 people in the United States are diagnosed
with Leukemia, Lymphoma, or Myeloma. At the present time, an estimated
670,950 Americans have blood cancers. Approximately 57,500 Americans
will die from these hematological malignancies this year. In New York
State alone, there are approximately 6,600 people diagnosed with a blood
cancer each year and 3,500 people will succumb to this disease.

 
PRIOR LEGISLATIVE HISTORY:

2016: A.49-A Passed Assembly S.1657-A Died in Senate Health
2015: A.49Passed Assembly S.1657 Died in Senate Finance
2014: A.558-A Passed Assembly S.1967-A Died in Senate Health
2013: A.558-A Passed Assembly S.1976-A Died in Senate Health
2012: A.0283 Passed Assembly S.0569 Died in Senate Health
2011: A.0283 Passed Assembly 5.0569 Died in Senate Health

 
FISCAL IMPLICATIONS:

Minimal to the state.

 
EFFECTIVE DATE:
This act shall apply to taxable years commencing on or after January 1,
2020.

2019-S4423 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4423
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                              March 11, 2019
                                ___________
 
 Introduced  by  Sen.  ROBACH -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, the tax law and the state finance
   law, in relation to providing for taxpayer gifts for leukemia, lympho-
   ma and myeloma research, education and treatment and establishing  the
   leukemia, lymphoma and myeloma research, education and treatment fund
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  article
 27-CCC to read as follows:
                              ARTICLE 27-CCC
 LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
 SECTION 2747. LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH, EDUCATION AND
                 TREATMENT.
   § 2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
 MENT.   THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A PROGRAM
 TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
 MA AND MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION,  THE  COMMIS-
 SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
   1.  TO  PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS DESIGNED TO
 REDUCE OR PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA,  LYMPHOMA  AND
 MYELOMA;
   2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
 ATIONS  AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS AS
 TO THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE  FUNDS
 BY THE STATE FINANCE LAW; AND
   3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
 MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
   § 2. The tax law is amended by adding a new section 209-M to  read  as
 follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00108-01-9

 S. 4423                             2
 
   §  209-M.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
 AND TREATMENT. EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANUARY
 FIRST, TWO THOUSAND TWENTY, A TAXPAYER IN ANY TAXABLE YEAR MAY ELECT  TO
 CONTRIBUTE  TO  THE  SUPPORT  OF  THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
 RESEARCH,  EDUCATION  AND  TREATMENT FUND. SUCH CONTRIBUTION SHALL BE IN
 ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
 OWED BY SUCH TAXPAYER. THE  COMMISSIONER  SHALL  INCLUDE  SPACE  ON  THE
 CORPORATE  INCOME  TAX RETURN TO ENABLE A TAXPAYER TO MAKE SUCH CONTRIB-
 UTION.  NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL   REVENUES
 COLLECTED  PURSUANT  TO  THIS SECTION SHALL BE CREDITED TO THE LEUKEMIA,
 LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
 USED ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-SSSS  OF
 THE STATE FINANCE LAW.
   §  3.  The tax law is amended by adding a new section 630-g to read as
 follows:
   § 630-G. GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION
 AND  TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANU-
 ARY FIRST, TWO THOUSAND TWENTY, AN INDIVIDUAL IN ANY  TAXABLE  YEAR  MAY
 ELECT  TO  CONTRIBUTE  TO  THE  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH,
 EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION SHALL BE  IN  ANY  WHOLE
 DOLLAR  AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY SUCH
 INDIVIDUAL. THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL  INCOME
 TAX  RETURN  TO  ENABLE  A TAXPAYER TO MAKE SUCH CONTRIBUTION.  NOTWITH-
 STANDING ANY OTHER PROVISION OF LAW ALL REVENUES COLLECTED  PURSUANT  TO
 THIS  SECTION  SHALL  BE  CREDITED TO THE LEUKEMIA, LYMPHOMA AND MYELOMA
 RESEARCH, EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE  PURPOSES
 ENUMERATED IN SECTION NINETY-SEVEN-SSSS OF THE STATE FINANCE LAW.
   §  4. The state finance law is amended by adding a new section 97-ssss
 to read as follows:
   § 97-SSSS. LEUKEMIA, LYMPHOMA  AND  MYELOMA  RESEARCH,  EDUCATION  AND
 TREATMENT  FUND.  1. THERE IS HEREBY ESTABLISHED IN THE JOINT CUSTODY OF
 THE COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A  SPECIAL
 FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
 TION AND TREATMENT FUND".
   2.  SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE DEPARTMENT
 OF TAXATION AND FINANCE, PURSUANT  TO  THE  PROVISIONS  OF  SECTION  TWO
 HUNDRED  NINE-M  AND SECTION SIX HUNDRED THIRTY-G OF THE TAX LAW AND ALL
 OTHER MONEYS APPROPRIATED, CREDITED, OR  TRANSFERRED  THERETO  FROM  ANY
 OTHER  FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS SECTION
 SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
 PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
 THE FUND ACCORDING TO LAW.
   2-A. ON OR BEFORE THE FIRST DAY OF FEBRUARY EACH YEAR, THE COMMISSION-
 ER OF HEALTH SHALL PROVIDE A WRITTEN REPORT TO THE  TEMPORARY  PRESIDENT
 OF  THE  SENATE,  THE  SPEAKER  OF THE ASSEMBLY, THE CHAIR OF THE SENATE
 FINANCE COMMITTEE, THE CHAIR OF THE ASSEMBLY WAYS AND  MEANS  COMMITTEE,
 THE  CHAIR  OF THE SENATE COMMITTEE ON HEALTH, THE CHAIR OF THE ASSEMBLY
 HEALTH COMMITTEE, THE STATE COMPTROLLER  AND  THE  PUBLIC.  SUCH  REPORT
 SHALL  INCLUDE  HOW  THE  MONIES  OF  THE  FUND WERE UTILIZED DURING THE
 PRECEDING CALENDAR YEAR, AND SHALL INCLUDE:
   (I) THE AMOUNT OF MONEY DISPERSED FROM THE FUND AND THE AWARD  PROCESS
 USED FOR SUCH DISBURSEMENTS;
   (II) RECIPIENTS OF AWARDS FROM THE FUND;
   (III) THE AMOUNT AWARDED TO EACH RECIPIENT;
   (IV) THE PURPOSES FOR WHICH SUCH AWARDS WERE GRANTED; AND

 S. 4423                             3
 
   (V) A SUMMARY FINANCIAL PLAN FOR SUCH MONIES WHICH SHALL INCLUDE ESTI-
 MATES OF ALL RECEIPTS AND ALL DISBURSEMENTS FOR THE CURRENT AND SUCCEED-
 ING  FISCAL  YEARS,  ALONG WITH THE ACTUAL RESULTS FROM THE PRIOR FISCAL
 YEAR.
   3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
 AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
 SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
 MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
 ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
 TREATMENT,  WHICH,  PURSUANT TO SECTION TWENTY-SEVEN HUNDRED FORTY-SEVEN
 OF THE PUBLIC HEALTH LAW, ARE APPROVED  BY  THE  DEPARTMENT  OF  HEALTH.
 SUCH  GRANTS  MAY  INCLUDE,  AMONG  OTHERS, GRANTS TO PUBLIC AND PRIVATE
 HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
   4. MONIES SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND  WARRANT  OF
 THE  COMPTROLLER  ON VOUCHERS APPROVED AND CERTIFIED BY THE COMMISSIONER
 OF HEALTH.
   5. TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL  ENSURE
 THAT  ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO THE
 END OF THAT FISCAL YEAR.
   § 5. This act shall take effect immediately and shall apply to taxable
 years commencing on or after January 1, 2020.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.